Semaglutide found to have the best outcomes in treating type 2 diabetes

25 Aug 2023

According to a study published in the Journal of Diabetes Complications, semaglutide is more effective in helping manage type 2 diabetes than other GLP-1 receptor agonists, including greater reductions in HbA1C, body weight, waist circumference and cardiometabolic improvements.


Hormones in the News